|
|
||||||||
Radiology, Vol 169, 45-48, Copyright © 1988 by Radiological Society of North America
ARTICLES |
MA Mintun, MJ Welch, BA Siegel, CJ Mathias, JW Brodack, AH McGuire and JA Katzenellenbogen
Edward Mallinckrodt Institute of Radiology, Washington University School of Medicine, St. Louis, MO 63110.
Thirteen patients with primary breast masses were studied with positron emission tomography (PET) and 16 alpha-[fluorine-18]-fluoroestradiol-17 beta. PET images demonstrated uptake of the labeled estrogen analog at sites of primary carcinomas and in several foci of axillary lymph node metastases, as well as in one distant metastatic site. There was excellent correlation between uptake within the primary tumor measured on the PET images and the tumor estrogen-receptor concentration measured in vitro after excision (r = .96). This technique may provide an in vivo method of assessing estrogen receptors in primary and metastatic breast cancers and thus guide management of this disease with antiestrogen chemotherapy.
This article has been cited by other articles:
![]() |
T. Tsujikawa, Y. Yoshida, T. Mori, T. Kurokawa, Y. Fujibayashi, F. Kotsuji, and H. Okazawa Uterine Tumors: Pathophysiologic Imaging with 16{alpha}-[18F]fluoro-17{beta}-estradiol and 18F Fluorodeoxyglucose PET--Initial Experience Radiology, August 1, 2008; 248(2): 599 - 605. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. E. Parent, C. S. Dence, T. L. Sharp, M. J. Welch, and J. A. Katzenellenbogen 7{alpha}-18F-Fluoromethyl-Dihydrotestosterone and 7{alpha}-18F-Fluoromethyl-Nortestosterone: Ligands to Determine the Role of Sex Hormone-Binding Globulin for Steroidal Radiopharmaceuticals J. Nucl. Med., June 1, 2008; 49(6): 987 - 994. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. A. Mankoff, J. M. Link, H. M. Linden, L. Sundararajan, and K. A. Krohn Tumor Receptor Imaging J. Nucl. Med., June 1, 2008; 49(Suppl_2): 149S - 163S. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. M. Peterson, D. A. Mankoff, T. Lawton, K. Yagle, E. K. Schubert, S. Stekhova, A. Gown, J. M. Link, T. Tewson, and K. A. Krohn Quantitative Imaging of Estrogen Receptor Expression in Breast Cancer with PET and 18F-Fluoroestradiol J. Nucl. Med., March 1, 2008; 49(3): 367 - 374. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. L. Kesner, W.-A. Hsueh, N. L. Htet, B. S. Pio, J. Czernin, M. D. Pegram, M. E. Phelps, and D. H.S. Silverman Biodistribution and Predictive Value of 18F-Fluorocyclophosphamide in Mice Bearing Human Breast Cancer Xenografts J. Nucl. Med., December 1, 2007; 48(12): 2021 - 2027. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. A. Mankoff, J. F. Eary, J. M. Link, M. Muzi, J. G. Rajendran, A. M. Spence, and K. A. Krohn Tumor-Specific Positron Emission Tomography Imaging in Patients: [18F] Fluorodeoxyglucose and Beyond Clin. Cancer Res., June 15, 2007; 13(12): 3460 - 3469. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. P. Kanne, D. A. Mankoff, G. S. Baird, S. Minoshima, and R. B. Livingston Gastric Linitis Plastica from Metastatic Breast Carcinoma: FDG and FES PET Appearances Am. J. Roentgenol., June 1, 2007; 188(6): W503 - W505. [Full Text] [PDF] |
||||
![]() |
W. A. Weber Positron Emission Tomography As an Imaging Biomarker J. Clin. Oncol., July 10, 2006; 24(20): 3282 - 3292. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. M. Linden, S. A. Stekhova, J. M. Link, J. R. Gralow, R. B. Livingston, G. K. Ellis, P. H. Petra, L. M. Peterson, E. K. Schubert, L. K. Dunnwald, et al. Quantitative Fluoroestradiol Positron Emission Tomography Imaging Predicts Response to Endocrine Treatment in Breast Cancer J. Clin. Oncol., June 20, 2006; 24(18): 2793 - 2799. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. J. Kelloff, K. A. Krohn, S. M. Larson, R. Weissleder, D. A. Mankoff, J. M. Hoffman, J. M. Link, K. Z. Guyton, W. C. Eckelman, H. I. Scher, et al. The Progress and Promise of Molecular Imaging Probes in Oncologic Drug Development Clin. Cancer Res., November 15, 2005; 11(22): 7967 - 7985. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Van Den Bossche and C. Van de Wiele Receptor Imaging in Oncology by Means of Nuclear Medicine: Current Status J. Clin. Oncol., September 1, 2004; 22(17): 3593 - 3607. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J. Bennink, G. van Tienhoven, L. J. Rijks, A. L. Noorduyn, A. G. Janssen, and G. W. Sloof In Vivo Prediction of Response to Antiestrogen Treatment in Estrogen Receptor-Positive Breast Cancer J. Nucl. Med., January 1, 2004; 45(1): 1 - 7. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. B. Eubank, D. A. Mankoff, H. J. Vesselle, J. F. Eary, E. K. Schubert, L. K. Dunnwald, S. K. Lindsley, J. R. Gralow, M. M. Austin-Seymour, G. K. Ellis, et al. Detection of Locoregional and Distant Recurrences in Breast Cancer Patients by Using FDG PET RadioGraphics, January 1, 2002; 22(1): 5 - 17. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J. Bennink, L. J. Rijks, G. van Tienhoven, L. A. Noorduyn, A. G. Janssen, and G. W. Sloof Estrogen Receptor Status in Primary Breast Cancer: Iodine 123-labeled cis-11{beta}-Methoxy-17{alpha}-iodovinyl Estradiol Scintigraphy Radiology, September 1, 2001; 220(3): 774 - 779. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. E. Mortimer, F. Dehdashti, B. A. Siegel, K. Trinkaus, J. A. Katzenellenbogen, and M. J. Welch Metabolic Flare: Indicator of Hormone Responsiveness in Advanced Breast Cancer J. Clin. Oncol., June 1, 2001; 19(11): 2797 - 2803. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. A. Mankoff, L. M. Peterson, T. J. Tewson, J. M. Link, J. R. Gralow, M. M. Graham, and K. A. Krohn [18F]Fluoroestradiol Radiation Dosimetry in Human PET Studies J. Nucl. Med., April 1, 2001; 42(4): 679 - 684. [Abstract] [Full Text] |
||||
![]() |
H.-A. Lehr, D. A. Mankoff, D. Corwin, G. Santeusanio, and A. M. Gown Application of Photoshop-based Image Analysis to Quantification of Hormone Receptor Expression in Breast Cancer J. Histochem. Cytochem., November 1, 1997; 45(11): 1559 - 1566. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| RADIOLOGY | RADIOGRAPHICS | RSNA JOURNALS ONLINE |